Literature DB >> 6120286

Acyclovir inhibits hepatitis B virus replication in man.

I V Weller, V Carreno, M J Fowler, J Monjardino, D Makinen, H C Thomas, S Sherlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6120286     DOI： 10.1016/s0140-6736(82)90990-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Antiviral therapy and resistance with hepatitis B virus infection.

Authors:  Hans L Tillmann
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases.

Authors:  O Hantz; T Ooka; L Vitvitski; C Pichoud; C Trepo
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

Review 3.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

Review 4.  The need for new antiviral agents.

Authors:  D S Freestone
Journal:  Antiviral Res       Date:  1985-12       Impact factor: 5.970
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.